Apellis Pharmaceuticals
Global biopharma company leveraging courageous science, creativity, and compassion to deliver life-changing therapies.
- Location
- —
- Roles tracked
- 0
- In pipeline
- 0
- Tracking since
- —
At a glance
You're tracking 0 roles at Apellis Pharmaceuticals. Track a role to start building momentum here.
Company intel
From the job board · LinkedIn data via posting sync- Industry
- Biotechnology Research
- Company size
- 501 people
- Headquarters
- Waltham, MA +2 more
- Founded
- 2008
- Type
- Public Company
- Total funding
- $919.6M
Apellis has been acquired by Biogen. Please follow along there for the latest news. This page is no longer updated or monitored.
Targeted C3 Therapies
Complement System
Hematology
Ophthalmology
Nephrology
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Geographic Atrophy (GA)
C3 Glomerulopathy (C3G)
Gene Therapy
and Neurology
Open roles at Apellis Pharmaceuticals
- Senior Manager, Business Intelligence, Syfovre Apellis Pharmaceuticals · Cambridge, Massachusetts, United States · $142K–$190K/yr
- Director, Business Intelligence, PNH Apellis Pharmaceuticals · Cambridge, Massachusetts, United States
- Associate Director, Business Intelligence, SYFOVRE Apellis Pharmaceuticals · Cambridge, Massachusetts, United States
